s6y
Company name or ticker
Search
Neumora Therapeutics, Inc.
4
CRANDELL KEITH: Statement of changes in beneficial ownership of securities
Filed
Monday, November 13, 2023
Period
Nov 8, 2023
Accession number
0001062993-23-020712
Documents
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
4
On sec.gov
Filing index
All files
Complete submission text
SGML header